Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Pilot Study Evaluating the Role of Histopathology Correlation in Treatment Planning [NA]
A completed pilot clinical trial evaluating histopathology correlation for informing prostate cancer treatment planning.
-
FDA approval · 2020-07-10FDA Approved: ERLEADA — Supplemental Application (Janssen Products, LP)
The FDA approved a supplemental application for ERLEADA (apalutamide) submitted by Janssen Products, LP, resulting in an expanded or updated…
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery) [Phase 2]
Phase 2 clinical trial update evaluating androgen deprivation therapy alone versus with definitive treatment (radiation or surgery) in prost…
-
CLINICAL_TRIALS trial_result · 2020-06-29Clinical Trial Update: Ketoconazole and Dexamethasone in Prostate Cancer [Phase 2]
Phase 2 clinical trial update involving ketoconazole and dexamethasone in prostate cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-06-26Clinical Trial Update: Circulating Tumor Cells in High-Risk Prostate Cancer Treated With High-dose Radiotherapy and Hormone Therapy
A completed clinical trial evaluating circulating tumor cells in high-risk prostate cancer patients treated with high-dose radiotherapy and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-06-25Clinical Trial Update: Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer [Phase 2]
Phase 2 trial investigating docetaxel or abiraterone acetate with androgen deprivation therapy for metastatic hormone-sensitive prostate can…
-
CLINICAL_TRIALS trial_result · 2020-06-24Clinical Trial Update: 68Ga-THP-PSMA PET/CT Imaging in High Risk Primary Prostate Cancer or Biochemical Recurrence of Prostate Cancer [Phase 2]
Phase 2 clinical trial update on 68Ga-THP-PSMA PET/CT imaging for high-risk primary or recurrent prostate cancer; results posted after compl…
-
CLINICAL_TRIALS trial_result · 2020-06-12Clinical Trial Update: PSMA-specific CAR-T Cell Therapy [Phase 1, Phase 2]
A phase 1/2 clinical trial update for a PSMA-specific CAR-T cell therapy is underway for PSMA-positive tumors or tumor tissues.
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: 68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks [Phase 2]
Phase 2 trial comparing 68Ga-RM2 to 68Ga-PSMA-617 PET/CT for imaging prostate cancer across different metastatic risk categories has complet…
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid Tumours [Phase 1, Phase 2]
Phase 1/2 trial of RV001V, a RhoC anticancer vaccine, for metastasis prevention in prostate cancer completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: A Phase II Study to Evaluate Axumin PET/CT for Risk Stratification for Prostate Cancer [Phase 2]
Phase II study evaluating Axumin PET/CT for risk stratification in prostate cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: Prostate Boost Irradiation With Stereotactic Body RT (SBRT) [Phase 2]
Phase 2 clinical trial update evaluating prostate boost irradiation using stereotactic body radiotherapy (SBRT) for prostate cancer.
-
CLINICAL_TRIALS trial_result · 2020-06-02Clinical Trial Update: FLAME: Investigate the Benefit of a Focal Lesion Ablative Microboost in Prostate Cancer [Phase 3]
Phase 3 trial update evaluating focal lesion ablative microboost in prostate cancer radiotherapy; study completed.
-
CLINICAL_TRIALS trial_result · 2020-06-01Clinical Trial Update: Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer [Phase 2]
Phase 2 trial evaluating supportive therapy in conjunction with androgen deprivation for prostate adenocarcinoma; study terminated with resu…
-
CLINICAL_TRIALS trial_result · 2020-06-01Clinical Trial Update: Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer [Phase 3]
Phase 3 trial evaluating enzalutamide with or without abiraterone and prednisone in castration-resistant metastatic prostate cancer; status …
-
CLINICAL_TRIALS trial_result · 2020-05-28Clinical Trial Update: Vaccine Treatment for Hormone Refractory Prostate Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial update for a vaccine treatment targeting hormone-refractory prostate cancer has completed enrollment and/or data …
-
CLINICAL_TRIALS trial_result · 2020-05-22Clinical Trial Update: A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer [Phase 2]
Phase II study of PX-866 in recurrent or metastatic castration-resistant prostate cancer has completed; results posted.
-
FDA approval · 2020-05-18FDA Approved: ABIRATERONE ACETATE — Original Application (Dr. Reddys Laboratories Inc)
FDA approved Dr. Reddy's Laboratories Inc's original application for Abiraterone acetate, enabling a generic version of the cancer drug for …
-
CLINICAL_TRIALS trial_result · 2020-05-13Clinical Trial Update: A Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer Patients [Phase 1, Phase 2]
Clinical trial update for SHR3680 in metastatic castration-resistant prostate cancer across Phase 1 and Phase 2, with unknown status.
-
CLINICAL_TRIALS trial_result · 2020-05-07Clinical Trial Update: Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer [Phase 2]
Phase 2 trial evaluating dendritic cell-based vaccines loaded with allogeneic prostate cell lines in combination with androgen ablation for …
-
CLINICAL_TRIALS trial_result · 2020-05-05Clinical Trial Update: A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC) [Phase 2]
Phase 2 PET/CT imaging study in patients receiving enzalutamide for castration-resistant prostate cancer with bone metastases has completed …
-
CLINICAL_TRIALS trial_result · 2020-05-04Clinical Trial Update: Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate Cancer [Phase 3]
Phase 3 trial update assessing safety, efficacy, and pharmacokinetics of leuprolide mesylate (LMIS 25 mg) in subjects with prostate cancer; …
-
CLINICAL_TRIALS trial_result · 2020-05-04Clinical Trial Update: Early Changes In Multiparametric MRI In Prostate Cancer [NA]
Clinical trial update on early changes in multiparametric MRI in prostate cancer; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2020-04-28Clinical Trial Update: Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence [Phase 3]
Phase 3 randomized trial of adjuvant hormonal therapy after surgery in high-risk prostate cancer; trial status terminated with results poste…
-
CLINICAL_TRIALS trial_result · 2020-04-28Clinical Trial Update: A Study of Effects of Fesoterodine in Men at High Risk for Overactive Bladder/Detrusor Overactivity Post Robotic-Assisted Lap. Prostatectomy [Phase 4]
Phase 4 trial evaluating the effects of fesoterodine in men at high risk for overactive bladder/detrusor overactivity after robotic-assisted…